Covaxin for the USA market. Ocugen, which is working towards the submission of the emergency use application in the US, will simultaneously seek authorisation under interim order for emergency use in Canada Shankar Musunuri, Chairman of the Board, Chief Executive Officer, and Co-founder of Ocugen said in a press release. "This amendment to expand our rights to commercialize Covaxin into Canada speaks of our strong relationship with Bharat Biotech and our joint dedication to bring this unique yet traditional vaccine to additional countries," Musunuri said.
As the consideration for Bharat Biotechs grant of the rights to commercialise Covaxin in Canada, Ocugen will make an upfront payment and milestone payment upon first commercial sale in.